date,title,source
Nov-07-18,Bellerophon Therapeutics: 3Q Earnings Snapshot,Associated Press
Nov-07-18,Bellerophon Provides Business Update and Reports Third Quarter 2018 Financial Results,GlobeNewswire
Nov-21-18,"Analysis: Positioning to Benefit within KemPharm, Bellerophon Therapeutics, Exela Technologies, Intec Pharma, Cerecor, and Chiasma  Research Highlights Growth, Revenue, and Consolidated Results",GlobeNewswire
Jan-22-19,"Bellerophon Therapeutics, Inc. Announces Proposed Public Offering of Common Stock",GlobeNewswire
Jan-23-19,Bellerophon Announces Pricing of $7 Million Public Offering of Common Stock,GlobeNewswire
Jan-25-19,Bellerophon Announces Closing of $7 Million Public Offering of Common Stock,GlobeNewswire
Jan-28-19,Bellerophon to Present Clinical Data Supporting Actigraphy as a Clinically Meaningful Endpoint to Detect Improvements in Pulmonary Fibrosis Patients,GlobeNewswire
